<DOC>
	<DOCNO>NCT02342626</DOCNO>
	<brief_summary>The overall goal project test interactive , multi-media decision aid form electronic clinical decision dashboard design improve quality clinical decision make initial treatment patient newly diagnose , low intermediate risk prostate cancer .</brief_summary>
	<brief_title>Devel . Eval . Active Surveillance Decision Aid Men With Low Intermediate Grade Prostate Cancer</brief_title>
	<detailed_description>The overall goal project test interactive , multi-media decision aid form electronic clinical decision dashboard design improve quality clinical decision make initial treatment patient newly diagnose , low intermediate risk prostate cancer . Specifically , propose conduct clinical trial compare effect prostate decision dashboard versus usual care : 1. patient knowledge regard treatment option available low intermediate risk prostate cancer , 2. measure decision make process include decisional conflict extent decision make via share decision make process , 3. treatment select , 4 . 3-6 9-12 month outcome assessment clinical status , decision regret , cancer-related quality life include worry , functional status , treatment side effect .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Age : 40 85 year Sex : male Race/ethnicity : restriction Diagnosis : Patients eligible study yet decide management plan present either : localize , low grade prostate cancer , define Gleason score â‰¤ 6 , T1T2a stage cancer , PSA value &lt; 10 ng/ml , OR Intermediate risk prostate cancer , define Gleason score = 7 , T2bT2c stage cancer ( tumor involve prostate extend beyond prostatic capsule ) , PSA 1020 ng/ml Willing participate able give inform consent Able adequately see study intervention interactive decision dashboard &amp; complete studyrelated questionnaire Able understand English language adequately use decision dashboard complete studyrelated questionnaire Unable complete studyrelated task due cognitive deficit English nonfluency Unwilling participate . Deemed clinically unsuitable active surveillance prostate cancer management option</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prostate</keyword>
	<keyword>Cancer</keyword>
	<keyword>Adenocarcinoma</keyword>
</DOC>